|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rack B, Schindlbeck C, Jückstock J,
Andergassen U, Hepp P, Zwingers T, Friedl TW, Lorenz R, Tesch H,
Fasching PA, et al: Circulating tumor cells predict survival in
early average-to-high risk breast cancer patients. J Natl Cancer
Inst. 106:pii: dju066. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen YY and Xu GB: Effect of circulating
tumor cells combined with negative enrichment and CD45-FISH
identification in diagnosis, therapy monitoring and prognosis of
primary lung cancer. Med Oncol. 31:2402014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kulasinghe A, Perry C, Jovanovic L, Nelson
C and Punyadeera C: Circulating tumour cells in metastatic head and
neck cancers. Int J Cancer. 136:2515–2523. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ning N, Zhan T, Zhang Y, Chen Q, Feng F,
Yang Z, Liu Z, Xu D, Wang F, Guo Y, et al: Improvement of specific
detection of circulating tumor cells using combined CD45 staining
and fluorescence in situ hybridization. Clin Chim Acta. 433:69–75.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Si Y, Lan G, Deng Z, Wang Y, Lu Y, Qin Y,
Huang B, Yang Y, Weng J, Han X, et al: Distribution and clinical
significance of circulating tumor cells in nasopharyngeal
carcinoma. Jpn J Clin Oncol. 46:622–630. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He C, Huang X, Su X, Tang T, Zhang X, Ma
J, Guo X and Lv X: The association between circulating tumor cells
and Epstein-Barr virus activation in patients with nasopharyngeal
carcinoma. Cancer Biol Ther. 18:888–894. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu Y, Qian Y, Peng J, Wei X, Yuan Z, Wei S
and Hu D: Clinical evaluation of circulating tumor cells in locally
advanced nasopharyngeal carcinoma: A prospective study. J Clin
Oncol. 35:e175232017.
|
|
9
|
Krebs MG, Sloane R, Priest L, Lancashire
L, Hou JM, Greystoke A, Ward TH, Ferraldeschi R, Hughes A, Clack G,
et al: Evaluation and prognostic significance of circulating tumor
cells in patients with non-small cell lung cancer. J Clin Oncol.
29:1556–1563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Wang F, Ning N, Chen Q, Yang Z,
Guo Y, Xu D, Zhang D, Zhan T and Cui W: Patterns of circulating
tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
Int J Cancer. 136:1228–1233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okabe H, Tsunoda S, Hosogi H, Hisamori S,
Tanaka E, Tanaka S and Sakai Y: Circulating tumor cells as an
independent predictor of survival in advanced gastric cancer. Ann
Surg Oncol. 22:3954–3961. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim HJ, Choi GS, Park JS, Park S, Kawai K
and Watanabe T: Clinical significance of thrombocytosis before
preoperative chemoradiotherapy in rectal cancer: Predicting
pathologic tumor response and oncologic outcome. Ann Surg Oncol.
22:513–519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Santos MF, Mannam VK, Craft BS, Puneky LV,
Sheehan NT, Lewis RE and Cruse JM: Comparative analysis of innate
immune system function in metastatic breast, colorectal, and
prostate cancer patients with circulating tumor cells. Exp Mol
Pathol. 96:367–374. 2014. View Article : Google Scholar : PubMed/NCBI
|
